Temporal Dynamics of Host Molecular Responses Differentiate Symptomatic and Asymptomatic Influenza A Infection

English version České info

Exposure to influenza viruses is necessary, but not sufficient, for healthy human hosts to develop symptomatic illness. The host response is an important determinant of disease progression. In order to delineate host molecular responses that differentiate symptomatic and asymptomatic Influenza A infection, we inoculated 17 healthy adults with live influenza (H3N2/Wisconsin) and examined changes in host peripheral blood gene expression at 16 timepoints over 132 hours. Here we present distinct transcriptional dynamics of host responses unique to asymptomatic and symptomatic infections. We show that symptomatic hosts invoke, simultaneously, multiple pattern recognition receptors-mediated antiviral and inflammatory responses that may relate to virus-induced oxidative stress. In contrast, asymptomatic subjects tightly regulate these responses and exhibit elevated expression of genes that function in antioxidant responses and cell-mediated responses. We reveal an ab initio molecular signature that strongly correlates to symptomatic clinical disease and biomarkers whose expression patterns best discriminate early from late phases of infection. Our results establish a temporal pattern of host molecular responses that differentiates symptomatic from asymptomatic infections and reveals an asymptomatic host-unique non-passive response signature, suggesting novel putative molecular targets for both prognostic assessment and ameliorative therapeutic intervention in seasonal and pandemic influenza.

Vyšlo v časopise: Temporal Dynamics of Host Molecular Responses Differentiate Symptomatic and Asymptomatic Influenza A Infection. PLoS Genet 7(8): e32767. doi:10.1371/journal.pgen.1002234
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002234

Souhrn

Zdroje

1. CoxNJSubbaraoK 1999 Influenza. Lancet 354 1277 1282

2. CarratFVerguEFergusonNMLemaitreMCauchemezS 2008 Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167 775 785

3. de JongMDSimmonsCPThanhTTHienVMSmithGJ 2006 Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12 1203 1207

4. PaleseP 2004 Influenza: old and new threats. Nat Med 10 S82 87

5. KawaiTAkiraS 2007 TLR signaling. Semin Immunol 19 24 32

6. StetsonDBMedzhitovR 2006 Type I interferons in host defense. Immunity 25 373 381

7. KawaiTSatoSIshiiKJCobanCHemmiH 2004 Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5 1061 1068

8. HondaKYanaiHNegishiHAsagiriMSatoM 2005 IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 772 777

9. TakaokaAYanaiHKondoSDuncanGNegishiH 2005 Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 243 249

10. YamamotoMSatoSHemmiHHoshinoKKaishoT 2003 Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 640 643

11. IchinoheTLeeHKOguraYFlavellRIwasakiA 2009 Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206 79 87

12. YoneyamaMKikuchiMNatsukawaTShinobuNImaizumiT 2004 The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 730 737

13. ZhuQEgelstonCVivekanandhanAUematsuSAkiraS 2008 Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci U S A 105 16260 16265

14. FennerJEStarrRCornishALZhangJGMetcalfD 2006 Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 7 33 39

15. RyoATsurutaniNOhbaKKimuraRKomanoJ 2008 SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc Natl Acad Sci U S A 105 294 299

16. ProudDTurnerRBWintherBWiehlerSTiesmanJP 2008 Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Respir Crit Care Med 178 962 968

17. ZaasAKChenMVarkeyJVeldmanTHeroAO3rd 2009 Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6 207 217

18. JacksonGGDowlingHFSpiesmanIGBoandAV 1958 Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med 101 267 278

19. DobigeonNMoussaouiSCoulonMTourneretJ-YHeroA 2009 Joint Bayesian endmember extraction and linear unmixing for hyperspectral imagery. IEEE Trans on Signal Processing 57 4355 4368

20. StoreyJDXiaoWLeekJTTompkinsRGDavisRW 2005 Significance analysis of time course microarray experiments. Proc Natl Acad Sci U S A 102 12837 12842

21. KohonenT 1995 Self-Organizing Maps. Series in Information Sciences 30

22. BühlmannPHothornT 2007 Boosting algorithms: regularization, prediction and model fitting. . Statistical Science 22 477 505

23. SamuelCE 2001 Antiviral actions of interferons. Clin Microbiol Rev 14 778 809, table of contents

24. MandersonAPBottoMWalportMJ 2004 The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22 431 456

25. ShapiraSDGat-ViksIShumBODricotAde GraceMM 2009 A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139 1255 1267

26. AndrejevaJChildsKSYoungDFCarlosTSStockN 2004 The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101 17264 17269

27. KangDCGopalkrishnanRVWuQJankowskyEPyleAM 2002 mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U S A 99 637 642

28. HemmiHKaishoTTakeuchiOSatoSSanjoH 2002 Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3 196 200

29. AkiraSUematsuSTakeuchiO 2006 Pathogen recognition and innate immunity. Cell 124 783 801

30. PulliamLSunBRempelH 2004 Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157 93 98

31. ChenGShawMHKimYGNunezG 2009 NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 4 365 398

32. KannegantiTDOzorenNBody-MalapelMAmerAParkJH 2006 Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440 233 236

33. KobayashiKSChamaillardMOguraYHenegariuOInoharaN 2005 Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 731 734

34. SabbahAChangTHHarnackRFrohlichVTominagaK 2009 Activation of innate immune antiviral responses by Nod2. Nat Immunol 10 1073 1080

35. MartinonFBurnsKTschoppJ 2002 The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10 417 426

36. MartinonFTschoppJ 2005 NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26 447 454

37. DurandEAl Haj ZenAAddadFBrasseletCCaligiuriG 2005 Adenovirus-mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty. J Vasc Res 42 255 265

38. OdaTAkaikeTHamamotoTSuzukiFHiranoT 1989 Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244 974 976

39. PomboCMBonventreJVMolnarAKyriakisJForceT 1996 Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway. Embo J 15 4537 4546

40. YasukawaHSasakiAYoshimuraA 2000 Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18 143 164

41. RothlinCVGhoshSZunigaEIOldstoneMBLemkeG 2007 TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131 1124 1136

42. PothlichetJChignardMSi-TaharM 2008 Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 180 2034 2038

43. MachadoFSJohndrowJEEsperLDiasABaficaA 2006 Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 12 330 334

44. SekiYHayashiKMatsumotoASekiNTsukadaJ 2002 Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A 99 13003 13008

45. KormanBDKastnerDLGregersenPKRemmersEF 2008 STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 8 398 403

46. MaAKokaRBurkettP 2006 Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24 657 679

47. SchlunsKSLefrancoisL 2003 Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3 269 279

48. SunJCLeharSMBevanMJ 2006 Augmented IL-7 signaling during viral infection drives greater expansion of effector T cells but does not enhance memory. J Immunol 177 4458 4463

49. PalmerCDiehnMAlizadehAABrownPO 2006 Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 7 115

50. CillonizCPantin-JackwoodMJNiCGoodmanAGPengX 2010 Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol 84 7613 7624

51. CillonizCShinyaKPengXKorthMJProllSC 2009 Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 5 e1000604 doi:10.1371/journal.ppat.1000604

52. AbrahamCChoJH 2009 Inflammatory Bowel Disease. N Engl J Med 361 2066 2078

53. HugotJPChamaillardMZoualiHLesageSCezardJP 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 599 603

54. JoostenLAHeinhuisBAbdollahi-RoodsazSFerwerdaGLebourhisL 2008 Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis. Proc Natl Acad Sci U S A 105 9017 9022

55. VandermeerMThomasAKamimotoLReingoldAGershmanK 2009 Role of statins in preventing death among patients hospitalized with lab-confirmed influenza infections. Infectious Diseases Society of America Annual Meeting 706

56. KoflerSNickelTWeisM 2005 Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond) 108 205 213

57. FloydRAHensleyKJafferyFMaidtLRobinsonK 1999 Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. Life Sci 65 1893 1899

58. SchwarzKB 1996 Oxidative stress during viral infection: a review. Free Radic Biol Med 21 641 649

59. AllenICScullMAMooreCBHollEKMcElvania-TeKippeE 2009 The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 556 565

60. CastelliJCHasselBAWoodKALiXLAmemiyaK 1997 A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 186 967 972

61. SamuelCEKuhenKLGeorgeCXOrtegaLGRende-FournierR 1997 The PKR protein kinase–an interferon-inducible regulator of cell growth and differentiation. Int J Hematol 65 227 237

62. ClemensMJEliaA 1997 The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17 503 524

63. ZillioxMJParmigianiGGriffinDE 2006 Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci U S A 103 3363 3368

64. TurnerRB 2001 Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis 33 1865 1870

65. BarrettBBrownRVolandRMaberryRTurnerR 2006 Relations among questionnaire and laboratory measures of rhinovirus infection. Eur Respir J 28 358 363

66. BolstadBMIrizarryRAAstrandMSpeedTP 2003 A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 185 193

67. FarawayJ 2004 Linear Models with R. Chapman and Hall

68. HössjerO 2008 On the coefficient of determination for mixed regression models. Journal of Statistical Planning and Inference 138 3022 3038

69. HeroAFleuryG 2004 Pareto-optimal methods for gene ranking. Journal of VLSI Signal Processing 38 259 275

70. BenjaminiYHochbergY 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. . Journal of the Royal Statistical Society Series B 57 289 300

71. GoemanJJvan de GeerSAde KortFvan HouwelingenHC 2004 A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20 93 99

72. SubramanianATamayoPMoothaVKMukherjeeSEbertBL 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 15545 15550

73. BühlmannPYuB 2003 Boosting with the L2 loss: regression and classification. Journal of the American Statistical Association 98 324 339

74. EfronB 1979 Bootstrap Methods: Another Look at the Jackknife. The Annals of Statistics 7 1 26